Search for: "U.S. Pharmaceutical Corporation" Results 141 - 160 of 1,599
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Aug 2014, 7:00 am by Kelly Phillips Erb
He said: You have accountants going to some big corporations — multinational corporations but that are clearly U.S. [read post]
8 Apr 2022, 2:05 am by Editors
Counsel/Corporate Counsel, Commercial Transactions/Strategic Partnerships, Roofstock (San Francisco, CA) Associate General Counsel – Global Head of IP, www.princetonlegal.com (Princeton, NJ) AGC – Rapidly Growing Startup Healthcare Company, Beacon Hill Staffing Group (Boston, MA) In-House Corporate Counsel (full-time remote engagement), Latitude (New York, NY) Legal Counsel & Global Copyright Manager, Christie’s (New York, NY) Director, Corporate… [read post]
6 May 2018, 4:15 am by Steve Brachmann
Cordis Corporation et. al. which vacated and remanded a lower court’s ruling that claims of patent infringement alleged by Israeli pharmaceutical firm Medinol were barred by the equitable defense of laches. [read post]
8 Mar 2022, 8:09 am by Regan Zambri Long PLLC
Details of the settlement are in a report filed with the U.S. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
2 Oct 2010, 8:43 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
24 Feb 2014, 8:37 am by Ben Vernia
Endo Pharmaceuticals Inc. is a Delaware corporation headquartered in Malvern, Pa [read post]
21 May 2014, 5:18 am by Broc Romanek
Here’s news from Davis Polk: As expected, Senator Carl Levin and thirteen other Democratic Senators yesterday introduced a bill that would significantly limit, for a two-year period, the ability of U.S. corporations to engage in the type of acquisitive “inversion” transactions that have been increasingly completed or proposed by many U.S. corporations, particularly in the pharmaceutical sector.1 The typical acquisitive inversion… [read post]
2 Aug 2007, 11:08 am
Investors and U.S. corporate issuers came together as never before in 2007 to address a wide range of concerns and to better align views on corporate best practices. [read post]